Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eyenovia Inc (EYEN)  
$1.01 0.07 (7.74%) as of 4:30 Fri 5/3


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 24,880,000
Market Cap: 25.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5165 - $5.01
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eyenovia is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its microdose array print (MAP™) platform technology, branded the Optejet®. MicroPine is Co.'s topical therapy for the treatment of progressive myopia, a back-of-the-eye ocular disease associated with pathologic axial elongation and sclero-retinal stretching. MicroLine is Co.'s pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens that causes the gradual loss of the eye's ability to focus on near objects and impairs near visual acuity. Mydcombi™ is Co.'s fixed combination formulation of tropicamide-phenylephrine for mydriasis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 160,717 165,607 357,711 630,255
Total Buy Value $176,411 $183,061 $635,654 $1,128,089
Total People Bought 1 2 6 7
Total Buy Transactions 3 4 15 27
Total Shares Sold 0 0 4,000 234,000
Total Sell Value $0 $0 $13,560 $1,148,560
Total People Sold 0 0 1 2
Total Sell Transactions 0 0 1 5
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 143
  Page 3 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jacobson Rachel   –       •      –    2022-04-11 4 A $0.00 $0 D/D 3,289 3,289     -
   Benjamin Stephen Keith   –       •      –    2022-04-11 4 A $0.00 $0 D/D 3,289 3,289     -
   Mather Charles E Iv   –       •      –    2022-03-31 4 B $3.12 $12,460 D/D 4,000 41,322 0.01 -43%     
   Grant Stuart M.   –       –       •   2022-02-22 4 B $2.75 $115,500 D/D 42,000 4,827,124 0.01 -30%     
   Grant Stuart M.   –       –       •   2022-02-18 4 B $2.85 $28,500 D/D 10,000 4,785,124 0.01 -29%     
   Grant Stuart M.   –       –       •   2022-02-07 4 B $2.97 $107,009 D/D 36,030 4,775,124 0.01 -39%     
   Grant Stuart M.   –       –       •   2021-12-15 4 B $3.45 $345,000 D/D 100,000 4,723,989 0.01 -30%     
   Grant Stuart M.   –       –       •   2021-11-16 4 B $3.52 $88,000 D/D 25,000 4,623,989 0.01 -12%     
   Grant Stuart M.   –       –       •   2021-11-15 4 B $3.60 $272,750 D/D 75,000 4,598,989 0.01 -12%     
   Ianchulev Tsontcho CHIEF EXECUTIVE OFFICER   •       •      –    2021-11-03 4 B $4.04 $121,206 D/D 30,000 579,895 0.01 -30%     
   Grant Stuart M.   –       –       •   2021-10-29 4 B $3.74 $58,140 D/D 15,505 4,539,094 0.01 -30%     
   Rowe Michael M CHIEF OPERATING OFFICER   •       –      –    2021-10-27 4 B $4.14 $4,968 D/D 1,200 5,500 0.01 -28%     
   Grant Stuart M.   –       –       •   2021-10-26 4 B $4.00 $400,000 D/D 100,000 4,523,589 0.01 -26%     
   Grant Stuart M.   –       –       •   2021-10-25 4 B $4.00 $135,224 D/D 33,806 4,423,589 0.01 -29%     
   Rowe Michael M Chief Operating Officer   •       –      –    2021-09-13 4 B $4.40 $6,600 D/D 1,500 4,300 2.74 -28%     
   Grant Stuart M.   –       –       •   2021-08-19 4 B $3.96 $198,984 D/D 50,000 4,389,783 0.01 -4%     
   Grant Stuart M.   –       –       •   2021-08-18 4 B $3.93 $3,635 D/D 924 4,339,783 0.01 -5%     
   Grant Stuart M.   –       –       •   2021-08-17 4 B $4.00 $93,676 D/D 23,419 4,338,859 0.01 -4%     
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4/A D $5.42 $74,119 D/D (13,675) 66,537     -
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4 D $5.42 $77,300 D/D (14,262) 65,950     -
   Clasby Jennifer G VP, Regulatory and Clinical   •       –      –    2021-06-17 4 OE $1.95 $47,795 D/D 24,510 80,212     -
   Lee Kenneth B Jr Director   –       •      –    2021-06-15 4 B $5.41 $10,812 D/D 2,000 25,359 2.39 12%     
   Lee Kenneth B Jr Director   –       •      –    2021-06-14 4 B $5.47 $10,940 D/D 2,000 23,359 2.39 6%     
   Lee Kenneth B Jr Director   –       •      –    2021-06-11 4 B $5.38 $10,760 D/D 2,000 21,359 2.39 5%     
   Mather Charles E Iv Director   –       •      –    2021-05-28 4 B $4.76 $14,268 D/D 3,000 26,359 2.39 24%     
  143 Records found
  1  2  3  4  5  6   
  Page 3 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us